SCHEMBL22356372

SCHEMBL22356372

C=C(C)C(=O)OCCOc1ccc(Nc2nc(Nc3ccc(OCCO)cc3)nc(Nc3ccc(OCCOC(=O)C(=C)C)cc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.47
APEX1 P27695 1/20 0.47
HTT P42858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 2/20 0.43
JAK2 O60674 5/20 0.41
HDAC6 Q9UBN7 5/20 0.41
EGFR P00533 3/20 0.41
HDAC1 Q13547 4/20 0.40
SYK P43405 3/20 0.40
ALDH1A1 P00352 2/20 0.40
KCNH3 Q9ULD8 2/20 0.40
NPC1 O15118 1/20 0.40
KDM4E B2RXH2 1/20 0.39
NFKB1 P19838 1/20 0.39
BRAF P15056 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22356364 1.00 POLB (0.47) POLBAPEX1HTTTDP1MAPT
SCHEMBL22356358 0.95 KCNH3 (0.46) POLBAPEX1HTTTDP1MAPT
SCHEMBL22356369 0.95 POLB (0.51) POLBAPEX1HTTTDP1MAPT
SCHEMBL22356362 0.90 HTT (0.50) POLBAPEX1HTTTDP1MAPT
SCHEMBL22356357 0.90 HTT (0.50) POLBAPEX1HTTTDP1MAPT
SCHEMBL22356472 0.86 SYK (0.54) HTTJAK2HDAC6EGFRHDAC1
SCHEMBL22356365 0.86 SYK (0.54) HTTJAK2HDAC6EGFRHDAC1
SCHEMBL22356359 0.86 SYK (0.51) HTTJAK2HDAC6EGFRHDAC1
SCHEMBL22356466 0.81 THRB (0.55) MAPTJAK2EGFRSYKALDH1A1
SCHEMBL22356467 0.81 THRB (0.55) MAPTJAK2EGFRSYKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TREEEL CO., LTD (KR) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TYR, CRY2, CRY1 POLB 3485/4885APEX1 2060/4885HTT 2073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.